About Health Care Industry

BNET Healthcare provides daily industry trends and news coverage with insights for managers and executives, focusing on major health care providers, hospitals and facilities, insurance companies, and medical device manufacturers. In addition to detailed company profiles, you will find detailed industry analysis on new alliances and partnerships, healthcare products, medical patents, health care cost control, lawsuits, management and board changes, and all other important business issues.

Medifast, Part One: Weight-Loss Miracle or Pyramid Scheme?

By David Phillips | Sep 11, 2009

Maryland-based Medifast is one of the few weight-loss companies reporting year-on-year gains in its financial results in these dour economic times. Liquid protein drinks, raw foods, Scarsdale and Atkins — is the Medifast Meal Plan an amazing weight-loss product, or just another in a long list of fad diets?

Management boasts that it has been on the cutting edge of weight management offerings for almost 30 years, with an estimated 20,000 physicians nationwide having recommended Medifast as a treatment option to more than one million of their overweight patients. Medifast meals are formulated with low-fat protein and fiber, and are supposedly “clinically proven” to help users lose weight quickly — up to an alleged 20 pounds a month — through a process called ketosis, a metabolic state where the body is tricked into burning its own fat reserves.

Medifast uses both clinical research studies and retrospective analysis data from its Medifast clinics as the basis of its “clinically proven” claim. A review of the clinical studies provided by the company online and in regulatory filings, however, finds a troubling theme underlying most of the treatment protocols: simply, any one study examined was either too small (number of patients actually treated), or were too limited in sampling scope (patient ages, heath, etc.) to arrive at any unequivocal conclusions about the treatment efficacy.

For example, the clinical outcomes data most commonly referenced in Medifast literature — the “Multicenter Evaluation of Health Benefits and Weight Loss on the Medifast Weight Management Program” (conducted at the Johns Hopkins Weight Management Center) — is nothing more than a flawed, retrospective meta-analysis of Medifast Center participating patients with an overwhelming sampling bias: 83 percent and 90 percent of patients were female and Caucasian, respectively.

Arthur Frank, director of the George Washington University Weight Management Center, presciently noted in an online Barron’s interview back in 2006:

Any controlled-portion, formula diet, whether prepared by Medifast or Optifast or NutriSystem or even a GNC [vitamin] store will help you lose weight because they are easier to stay on and are intrinsically better because they take the individual out of the food decision-making process. You don’t necessarily need clinical tests to prove that.

In summary, flaws in study design invalidate the efficacy question: does the effect of dietary intervention with Medifast foods help patients to reduce body mass index (BMI) any better than other diet plans? And, as Frank brusquely said, “they’re all the same.” What then, accounts for the increasing popularity — as measured in sales — of Medifast products? Critics suggest the buzz behind the company has nothing to do with achieving the desired weight-loss goals or taste of Medifast meals-scrambled eggs, cheese puffs, or beef vegetable stew-and everything to do with the marketing behind the products.

Read part two for the case against Medifast’s financial success.

BNET User Analysis

Web Buzz:
  • Medifast, Part Two: Weight-Loss Miracle or Pyramid Scheme?

    BNET Healthcare - 151 days 8 hours 52 minutes ago

    (Note: See my previous post evaluating Medifast’s claims of a “clinically proven” weight-loss method.) Chief executive officer

  • Ciena suffers third quarter loss

    Financial Times - 159 days 11 hours 44 minutes ago

    Reduced spending by telecommunications network operators continued to hold back Ciena, the Maryland-based network equipment maker, but the company’s third quarter results were better than expected and the shares gained 5.7 per cent in morning trading on Thursday. Gary Smith, Ciena’s chief executive described the overall market as...

  • China Sky's Weight-Loss Patch Has a Questionable Future

    Seeking Alpha - 237 days 18 hours 33 minutes ago

    China Sky One Medical, Inc. CSKI states in its 10-K that its weight-loss patch product, the Sumei Slim Patch, is "believed to foster weight loss and prevent weight gain." The Sumei Slim Patch comprised 22% of China Sky's total sales in 2008, according to the company's fourth quarter earnings

  • Alli hits Europe, beefing up GSK's consumer line

    FiercePharma - 295 days 12 hours 39 minutes ago

    GlaxoSmithKline launched its nonprescription weight-loss drug alli in European pharmacies, boosting its line-up of consumer products in the region. Glaxo is eyeing its OTC meds for growth at a time when prescription drug sales are slowing down. Report

  • Maryland-based Marshall Management Changes Name to Marshall Hotels & Resorts, Inc.

    Hotel News Resource - 364 days 12 hours 57 minutes ago

    Maryland-based Marshall Management Changes Name to Marshall Hotels & Resorts, Inc. "We have essentially doubled in size over the past five years and now operate 48 hotels, with a total asset value in excess of $750 million," said Michael Marshall, president and CEO of Marshall Hotels & Resorts. "Our range of hotels now extends from...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here